Skip to main content
Have a personal or library account? Click to login
Early clinical outcomes and quality of life assessment after HeartMate 3 implantation: A single-centre descriptive study Cover

Early clinical outcomes and quality of life assessment after HeartMate 3 implantation: A single-centre descriptive study

Open Access
|Apr 2026

References

  1. Antonopoulos M, Bonios MJ, Dimopoulos S, et al. Advanced Heart Failure: Therapeutic Options and Challenges in the Evolving Field of Left Ventricular Assist Devices. J Cardiovasc Dev Dis. 2024;11(61):61.
  2. Binanay C, Califf RM, Hasselblad V, et al. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness. JAMA. 2005;294(13):1625–1633.
  3. Costanzo MR, Mills RM, Wynne J. Characteristics of “Stage D” heart failure: Insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM). Am Heart J. 2008;155(2):339–347.
  4. Tousoulis D. Advanced heart failure: Where do we stand? Hellenic J Cardiol. 2018;59(5):303–305.
  5. Jefferson HL, Kent WDT, MacQueen KT, et al. Left ventricular assist devices: A comprehensive review of major clinical trials, devices, and future directions. J Card Surg. 2021;36(5):1480–1491.
  6. Melendo-Viu M, Dobarro D, Raposeiras Roubin S, et al. Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection. Life (Basel). 2023;13(5):1065.
  7. Stehlik J, Kobashigawa J, Hunt SA, et al. Honoring 50 Years of Clinical Heart Transplantation in Circulation. Circulation. 2018;137(1):71–87.
  8. Stevenson LW, Pagani FD, Young JB, et al. INTERMACS Profiles of Advanced Heart Failure: The Current Picture. J Heart Lung Transplant. 2009;28(6):535–541.
  9. Saeed D, Feldman D, El Banayosy A, et al. The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10-Year Update. J Heart Lung Transplant. 2023;42(1):e1–e222.
  10. Potapov EV, Antonides C, Crespo-Leiro MG, et al. 2019 EACTS Expert Consensus on long-term mechanical circulatory support. Eur J Cardiothorac Surg. 2019;56(2):230–270.
  11. Han JJ, Acker MA, Atluri P. Left ventricular assist devices synergistic model between technology and medicine. Circulation. 2018;138. Epub ahead of print. doi:10.1161/CIRCULATIONAHA.118.035566.
  12. Meyer DM, Nayak A, Wood KL, et al. The Society of Thoracic Surgeons Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients. Ann Thorac Surg. Epub ahead of print October 2024. doi:10.1016/j.athoracsur.2024.10.003.
  13. Guglin M, Zucker MJ, Borlaug BA, et al. Evaluation for Heart Transplantation and LVAD Implantation. J Am Coll Cardiol. 2020;75(12):1471–1487.
  14. Roger VL. Epidemiology of Heart Failure. Circ Res. 2013;113(6):646–659.
  15. Goldstein DJ, Naka Y, Horstmanshof D, et al. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent. JAMA Cardiol. 2020;5(4):411–419.
  16. Varshney AS, DeFilippis EM, Cowger JA, et al. Trends and Outcomes of Left Ventricular Assist Device Therapy. J Am Coll Cardiol. 2022;79(11):1092–1107.
  17. Cordero-Cabán K, Ssembajjwe B, Patel J, et al. How to select a patient for LVAD. Indian J Thorac Cardiovasc Surg. 2023;39(1):8–17.
  18. Yuzefpolskaya M, Schroeder SE, Houston BA, et al. The Society of Thoracic Surgeons Intermacs 2022 Annual Report: Focus on the 2018 Heart Transplant Allocation System. Ann Thorac Surg. 2023;115(2):311–327.
  19. Asleh R, Briasoulis A, Schettle SD, et al. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices. Circ Heart Fail. 2017;10. Epub ahead of print. doi:10.1161/CIRCHEARTFAILURE.117.004213.
  20. Khan MS, Yuzefpolskaya M, Memon MM, et al. Outcomes Associated with Obesity in Patients Undergoing Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis. ASAIO J. 2020;66(4):401–408.
  21. Sreenivasan J, Kaul R, Khan MS, et al. Left Ventricular Assist Device Implantation in Hypertrophic and Restrictive Cardiomyopathy: A Systematic Review. ASAIO J. 2021;67(3):239–244.
  22. Truong VT, Shreenivas S, Mazur W, et al. Left Ventricular End-Diastolic Dimension and Clinical Outcomes After Centrifugal Flow Left Ventricular Assist Device Implantation. ASAIO J. 2022;68(2):220–225.
  23. Noly P-E, Duggal N, Jiang M, et al. Role of the mitral valve in left ventricular assist device pathophysiology. Front Cardiovasc Med. 2022;9:1018295. Epub ahead of print 28 Oct 2022. doi:10.3389/fcvm.2022.1018295.
  24. Fujino T, Imamura T, Nitta D, et al. Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2020;110(3):918–924.
  25. Al Saadi T, Andrade A, Chickerillo K, et al. A case series of patients with left ventricular assist devices and concomitant mechanical heart valves. Artif Organs. 2020;44(10):1050–1054.
  26. EuroSCORE. EuroSCORE Calculator. Available from: https://www.euroscore.org. Accessed 27 Aug 2025.
  27. Menon A, Mechelinck M, Unterkofler J, et al. Predictive Value of EuroSCORE II in Patients Undergoing Left Ventricular Assist Device Therapy. Thorac Cardiovasc Surg. 2015;64(6):475–482.
  28. Masarone D, Houston B, Falco L, et al. How to Select Patients for Left Ventricular Assist Devices? A Guide for Clinical Practice. J Clin Med. 2023;12(16):5216.
  29. Bansal N, Hailpern SM, Katz R, et al. Outcomes Associated With Left Ventricular Assist Devices Among Recipients With and Without End-stage Renal Disease. JAMA Intern Med. 2018;178(2):204–209.
  30. Elzeneini M, Mahmoud A, Elsayed AH, et al. Predictors of perioperative bleeding in left ventricular assist device implantation. Am Heart J Plus. 2021;2:100006.
  31. Lo Coco V, De Piero ME, Massimi G, et al. Right ventricular failure after left ventricular assist device implantation: A review of the literature. J Thorac Dis. 2021;13. Epub ahead of print. doi:10.21037/JTD-20-2228.
  32. Frankfurter C, Molinero M, Vishram-Nielsen JKK, et al. Predicting the Risk of Right Ventricular Failure in Patients Undergoing Left Ventricular Assist Device Implantation. Circ Heart Fail. 2020;13. Epub ahead of print. doi:10.1161/CIRCHEARTFAILURE.120.006994.
  33. Coromilas EJ, Takeda K, Ando M, et al. Comparison of Percutaneous and Surgical Right Ventricular Assist Device Support After Durable Left Ventricular Assist Device Insertion. J Card Fail. 2019;25(2):105–113.
  34. Siméon S, Flécher E, Revest M, et al. Left ventricular assist device-related infections: a multicentric study. Clin Microbiol Infect. 2017;23(10):748–751.
  35. Zierer A, Melby SJ, Voeller RK, et al. Late-Onset Driveline Infections: The Achilles' Heel of Prolonged Left Ventricular Assist Device Support. Ann Thorac Surg. 2007;84(2):515–520.
  36. Shah P, Tantry US, Bliden KP, et al. Bleeding and thrombosis associated with ventricular assist device therapy. J Heart Lung Transplant. 2017;36(11):1164–1173.
  37. Mehra MR, Netuka I, Uriel N, et al. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure. JAMA. 2023;330(22):2171–2179.
DOI: https://doi.org/10.62838/jccm-2026-0015 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 281 - 290
Submitted on: Sep 25, 2025
Accepted on: Jan 20, 2026
Published on: Apr 30, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Samuel Michelini, Marius Mihai Harpa, Dan Nistor, David-Emanuel Anitei, Alexandru Stan, Paul Calburean, Emil Marian Arbanasi, Dragos-Florin Baba, Sabrina Mancino, Horatiu Suciu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.